Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins

Microbial Drug Resistance

Volumn 6, Issue 4, 2000, Pages 297-303

  Urban, Carl ^a,b   Mariano, Noriel ^a,b   Rahman, Naim ^a,b   Queenan, Anne Marie ^a,b   Montenegro, Deborah ^a,b   Bush, Karen ^a,b   Rahal, James J ^a,b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; PROTEIN TEM 26; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; ENZYME DEFICIENCY; HYDROLYSIS; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RESTRICTION MAPPING;

BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORINS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; ISOELECTRIC FOCUSING; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE;

BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE;

EID: 0034476952     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2000.6.297     Document Type: Article

References (27)

1. Why are antibiotic resistance genes so resistant to elimination?
2. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: Roles of an infection control program and changes in aminoglycoside use
3. Antibiotic-selective environments
4. SHV-7, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli from hospitalized nursing home patients
5. Imipenem resistance of clinical isolates of Klebsiella pneumoniae results from ACT-1, a plasmid mediated AMP C β-lactamase combined with loss of membrane porin proteins
6. Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations
7. Extended-spectrum β-lactamases and other enzymes providing resistance to Oxyimino-β-lactams
8. The microbial genetics of antibiotic cycling
9. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary
10. Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics
11. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalo-sporins
12. Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergistic effect with co-amoxiclav due to SHV-1 hyperproduction
13. Evolution and dissemination of β-lactamases accelerated by generations of B-lactam antibiotics
14. Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins
15. The global nature of antimicrobial resistance and the need to monitor and manage it locally
16. Control of infections due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics
17. Class withdrawal of cephalosporins for control of total cephalosporin resistance in nosocomial Klebsiella
18. High level expression of chromosomally encoded SHV-1 β-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillintazobactam in a clinical isolate of Klebsiella pneumoniae
19. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
20. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A Streptococci in Finland
21. Society for healthcare epidemiology of America and infectious diseases society of America joint committee on the prevention of antimicrobial resistance: Guidelines for the prevention on antimicrobial resistance in hospitals
22. Azthreonam (SQ 26, 776), a synthetic monobactam specifically active against aerobic gram-negative bacteria
23. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital
24. Identification of TEM-26 β-lactamase responsible for a major outbreak of ceftazidime resistant Klebsiella pneumoniae
25. Klebsiella and extended spectrum β-lactamases